Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial dynamics regulatory proteins are a class of structurally and functionally distinct molecules that control the balanced processes of mitochondrial fission (division) and fusion (joining), which together dictate mitochondrial morphology, quality control, and distribution within the cell[2][3][6][8]. The main fission regulator is dynamin-related protein 1 (DRP1), a large cytosolic GTPase that is recruited to the mitochondrial outer membrane by adaptors such as mitochondrial fission factor (MFF), mitochondrial dynamics proteins of 49 kDa (MID49) and 51 kDa (MID51), and mitochondrial fission 1 protein (FIS1)[2][3][4]. Mitochondrial fusion is controlled by mitofusin 1 and 2 (MFN1, MFN2) at the outer membrane, and optic atrophy 1 (OPA1) at the inner membrane[3][5]. Regulation also involves Bcl-2 family proteins (Bax, Bak, Bcl-2, Bcl-xL) that modulate fission-fusion machinery during physiology and apoptosis[7]. These proteins are critical for cellular homeostasis, energy production, cell cycle, immune signal transduction, apoptosis, and response to cellular stress[1][3][5]. Deregulation or mutation of these proteins is implicated in neurodegenerative disease, cancer, cardiovascular disease, metabolic disorders, and degenerative cartilage diseases[5][6]. Given the complexity of the protein network and the broad disease relevance, "mitochondrial dynamics regulatory proteins" is a functionally descriptive ensemble but not a single molecular target; drug discovery and diagnostic work typically focus on individual proteins within this machinery (such as DRP1, MFN2, or OPA1)[2][4]. Agents that target these proteins usually block or promote fission/fusion to restore cellular balance in disease states.
Modulation of mitochondrial fission or fusion (inhibition or activation of key GTPases such as DRP1), Modulation of apoptotic threshold (by targeting Bcl-2/Bax/Bak interactions)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial dynamics regulatory protein.